Celexa
This anti-depressant drug, generically known as Citalopram, is widely used for its efficacy in treating a lot of disorders including anxiety disorders, depression and body dysmorphic. It is classified as an SSRI or selective serotonin reuptake inhibitor. Celexa works on unbalanced brain chemicals that causes depression.
Its original patent belonged to Lundbeck but other companies started to manufacture generic versions of the drug after the patent expiration in 2003. Thus, you can find Citalopram under the following brand names in specific countries:
* Celexa-United States
* Citrol, Cipramil or Seropram-Europe and in Australia
* Celepram or Ciazil-Australia
* Recital-Israel
* Zentius-South America
* Zetalo-India
* Cipram-Denmark
Patients who have a history or who have existing medical conditions like kidney problems, epilepsy, liver disease, bipolar disorder or drug abuse should not take Celexa without consulting with first consulting with his doctor. Celexa interacts negatively with monoamine oxidase inhibitors or MAOIs which includes Marplan, Azilect, Nardil, Eldepryl or Parnate. A person who is taking any MAOI medication should stop taking the medication and wait for two weeks before he should start taking in Celexa. The same thing should be done if the patient is taking in Celexa
but has to use an MAOI. It is not advisable to take medications for fever,arthritis or pain while taking Celexa as it can result to bleeding or bruising.
Most patients who are suffering from depression and its symptoms may have had suicidal thoughts before they took Celexa or similar medications. It is imperative that the patient call his doctor immediately if he feels new symptoms like:
* Anxiety
* Panic attacks
* Becoming more depressed
* Suicidal thoughts
* Agitation
* Irritability
Celexa is unsafe for a pregnant woman because it can result to fatal lung problems for the unborn child. However, there is also a danger of relapsing into depression once the pregnant woman stops taking the drug. It is best to inform the doctor
about this problem as soon as possible.
CELEXA NEWS HIGHLIGHTS
- Cognitive Behavioral Therapy Best for Traumatized Youths
(HealthDay) - Cognitive Behavioral Therapy Best for Traumatized Youths
(HealthDay) - Voice Problems in Seniors Undertreated
(HealthDay) - Stubborn asthma may signal poor use of meds
(Reuters) - Stubborn asthma may signal poor use of meds
(Reuters) - Stubborn asthma may signal poor use of meds
(Reuters) - Stubborn asthma may signal poor use of meds
(Reuters) - Thoughts of suicide long after childhood cancer
(Reuters) - Thoughts of suicide long after childhood cancer
(Reuters) - Thoughts of suicide long after childhood cancer
(Reuters) - Thoughts of suicide long after childhood cancer
(Reuters) - Thoughts of suicide long after childhood cancer
(Reuters) - ‘Green spaces’ tied to better health
(Reuters) - ‘Green spaces’ tied to better health
(Reuters) - European patent office restores breast cancer gene patent
(AFP) - Studies do not link heart risk to bone drugs: FDA
(Reuters) - Study Looks At Cost-Effectiveness of ECG in Hyperactive
Kids
(HealthDay) - Study Looks At Cost-Effectiveness of ECG in Hyperactive
Kids
(HealthDay) - Study Looks At Cost-Effectiveness of ECG in Hyperactive
Kids
(HealthDay) - Study Looks At Cost-Effectiveness of ECG in Hyperactive
Kids
(HealthDay) - Drugs for depression, anxiety tied to preterm birth
(Reuters) - FDA Finds No Link So Far Between Asthma Drugs and Suicide
Risk
(HealthDay) - New anti-psychotic medications as risky as older ones: study
(AFP) - New anti-psychotic medications as risky as older ones: study
(AFP) - Mood disorders common in polycystic ovary syndrome
(Reuters) - Acupuncture shows promise for depression in pregnancy
(Reuters) - Acupuncture shows promise for depression in pregnancy
(Reuters) - Acupuncture shows promise for depression in pregnancy
(Reuters) - Acupuncture shows promise for depression in pregnancy
(Reuters) - U.S. patent office rejects part of Viagra patent
(Reuters) - U.S. patent office rejects part of Viagra patent
(Reuters) - Self-Dosing Pain Medication Errors Too Common: Study
(HealthDay) - Self-Dosing Pain Medication Errors Too Common: Study
(HealthDay) - Self-Dosing Pain Medication Errors Too Common: Study
(HealthDay) - Quitting Smoking Tougher on Women
(HealthDay) - Quitting Smoking Tougher on Women
(HealthDay) - Premature birth tied to later behavioral problems
(Reuters) - Premature birth tied to later behavioral problems
(Reuters) - Patent pool to lower prices for AIDS treatments
(AFP) - Patent pool to lower prices for AIDS treatments
(AFP) - Patent pool to lower prices for AIDS treatments
(AFP) - Patent pool to lower prices for AIDS treatments
(AFP) - Anxiety does not up risk of post-surgery delirium: study
(Reuters) - Low Childhood IQ Tied to Risk of Later Mental Disorders
(HealthDay) - Medication Error Death Rate Up 500 Percent
- Genetic Predisposition May Play A Role In Anxiety Disorders
- The Alliance For Patient Medication Safety Submits Landmark Filing To Be A Patient Safety Organization, USA
- Suicidal Thoughts Not Uncommon Among US Students
- Sleep Disorders Program – Brigham And Women’s Hospital
- Fighters In Liberia More Likely To Have Mental Health Disorders After Exposure To Sexual Violence